<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Morphological Observation on Critical-Sized Cranial Defect Repaired by Icariin and Autologous Concentrate Growth Factors in Rabbits</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abce</forename><surname>Gang</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li</forename><surname>Abde</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jie</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bcd</forename><surname>Guiyun</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ren</forename><surname>Bcd</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fuliang</forename><surname>Hao</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">C</forename><surname>Yanning</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhang</forename><surname>Cdf</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peikai</forename><surname>Shi</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao</forename><surname>Liu</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ace</forename><forename type="middle">Fusheng</forename><surname>Dong</surname></persName>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fusheng</forename><surname>Dong</surname></persName>
							<email>fusheng_dong0129@sina.com</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Prosthodontics</orgName>
								<orgName type="institution">Stomatology Hospital of Hebei Medical University</orgName>
								<address>
									<settlement>Shijiazhuang</settlement>
									<region>Hebei</region>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Oral Pathology</orgName>
								<orgName type="institution">Stomatology Hospital of Hebei Medical University</orgName>
								<address>
									<settlement>Shijiazhuang</settlement>
									<region>Hebei</region>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Oral and Maxillofacial Surgery</orgName>
								<orgName type="institution">Stomatology Hospital of Hebei Medical University</orgName>
								<address>
									<settlement>Shijiazhuang</settlement>
									<region>Hebei</region>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Morphological Observation on Critical-Sized Cranial Defect Repaired by Icariin and Autologous Concentrate Growth Factors in Rabbits</title>
					</analytic>
					<monogr>
						<idno type="ISSN">1643-3750</idno>
					</monogr>
					<idno type="DOI">10.12659/MSM.900098</idno>
					<note type="submission">Received: 2016.06.15 Accepted: 2016.08.01 Published: 2017.05.19</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:53+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Critical Pathways</term>
					<term>Drugs, Chinese Herbal</term>
					<term>Morpholines</term>
					<term>Transplantation, Autologous This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Departmental sources Background: Morphological changes repaired by icariin and autologous concentrate growth factors (ACGF) in critical-sized cranial defect were observed and their promoting effects were investigated. Material/Methods: Seventy-two New Zealand white rabbits weighing 1.8~2.0kg were used to build a critical-sized cranial defect model and were randomly divided into 3 groups. X-ray, HE staining, general and histological observation, and immunohistochemistry were used to describe the changes caused by normal saline, icariin, and ACGF. Results: Cranial defects were covered with newly formed bone tissue at the 12 th week in icariin and ACGF groups, with red color, hard surface, and no obvious boundary. Densities were the same in 2 groups at 4 timepoints. HE staining showed defects filled with a large amount of fibrous connective tissue, thick collagen fibers, and abundant osteoclasts. No new bone matrix appeared in any of the 3 groups. Trabecular area, trabeculae width, and osteoblast number in 2 groups were more than that of the control group, and osteoclast number was lower. However, osteoclast number among the 3 groups at the 12 th week had no significant difference, which was the same with 4 indicators between the icariin and ACGF groups. From the 4 th to 12 th week, regenerated cartilage was formed and showed positive reaction with BMP-2 and TGFb1 from primary bone, which also was demonstrated by granulation tissue and uniform dyeing. Conclusions: ACGF and icariin both can increase new bone quantity and improve bone quality, which can also promote healing. The effects and mechanisms of icariin and ACGF on the expression of gene are not exactly the same.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Bone defects caused by various causes, especially oral and maxillofacial defects, have a serious impact on patient quality of life <ref type="bibr" target="#b0">[1]</ref>. Bone healing is an extremely complex process of biological repair, and has been a major problem in clinical practice. How to promote the healing of bone defect is a current focus of medical research. Scholars in China and other countries have done many experiments and widely discussed the bone healing mechanism with the help of histology, histochemistry, histology, ultrastructure, and biomechanics <ref type="bibr" target="#b1">[2]</ref>.</p><p>Chinese herbal medicine has a history of 7000 years in China. Icariin (C 33 H 40 O 15 , molecular weight 676.67), is an active component of Epimedium, and was reported to have physiological activities such as improving cardiovascular and cerebral vessels, enhancing the sexual glands and the immune system, delaying aging, resisting tumors and viruses, inhibiting osteoclast formation, and promoting osteoblast growth <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>. The mechanism of promoting bone repair and regeneration by icariin is well understood. Autologous concentrated growth factor (ACGF), a new type of biological material, was first proposed by Sacco <ref type="bibr" target="#b6">[7]</ref>. ACGF contains transfer growth factor b (TGF-b), bone morphogenetic protein (BMP), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (bFGF) <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>. Recent studies have shown that ACGF has the ability to promote new bone formation and implant bone bonding, and shortens the time required for this process <ref type="bibr" target="#b9">[10]</ref>. In a certain sense, ACGF can enhance the repair and regeneration of bone defects.</p><p>Using a critical-sized cranial defect model, we observed the effect of normal saline, icariin, and ACGF pellicle on bone defects. At 4 time points, the effects, characteristics, and speeds of osteoclast and osteoblast formation were compared to explore the mechanism of promoting healing of bone defects by general observation, X-ray, HE staining, and bone histomorphometry and immunohistochemistry.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and Methods</head><p>We randomly divided 72 healthy female New Zealand white rabbits weighing 1.8~2.0kg (12 months old, supplied by the Laboratory Animal Center of Hebei Medical University, SCXK(JI)2013-1-003, 1406115) into 3 groups and housed them individually.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Building a critical-sized cranial defect model</head><p>After rabbits were conventionally raised for a week, skull hair of the surgical area between the eyes and ears was removed with 8% Na 2 S the day before surgery. Under general anesthesia with 10% hydrate (0.15 mg/kg, FUYU Chemical, China), rabbits were fixed on the operating table in prone position. A 15-mm diameter cranial defect was made and the integrity of the dura mater was preserved to produce a cranial full-thickness defect <ref type="figure" target="#fig_0">(Figure 1</ref>). Gentamicin sulfate and sterile saline were used to wash the wound, preserving the integrity of the periosteum and covering the bone defect area. After the surgery, rabbits were returned to their cages after resuscitation and allowed free access to food and water. Each rabbit was injected with 80 000 units of gentamicin sulfate for 3 consecutive days.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Groups</head><p>Group A, the icariin group, was given intragastric administration of icariin in equal daily doses from the first day after suturing periosteum and skin. Icariin was administered daily as a 100-mg/ml solution (CY121120, Ciyuan Biotech Co., Ltd, China) and dosage was 100 mg/kg per day. In group B, the ACGF group, the local bone defect was covered with ACGF pellicle and then periosteum and skin were sutured. Group C, the control group, was given normal saline by gastric lavage before eating and dosage was 1 ml/kg once daily from the first day after suturing periosteum and skin.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACGF pellicle</head><p>Venous blood of rabbits was collected into 9-ml blood collection tubes (Vacuette, Austria) without shaking. After centrifugation with 30-s acceleration, 2700 r/min for 2 min, 2400 r/min for 4 min, 2700 r/min for 4 min, 3000 r/min for 3 min, and 36 s deceleration (ZilaDent, Italy), a middle layer of yellow jelly material formed. Which was the ACGF gel layer. An ACGF pellicle was produced using a mold.    the data between 2 groups. P values less than 0.05 were considered significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The general observation of bone defect was done and the changes are shown in week. Local high-density bone was found in the defect area and the defect area was obviously smaller with edges blurred. There was no significant difference between groups A and B (P&gt;0.05, <ref type="figure" target="#fig_2">Figure 4</ref>).  Results of HE staining revealed bone defects were filled with fibrous connective tissue and no new bone tissue appeared at the 2 nd week in all 3 groups. OCN was abundant. Two weeks later, in groups A and B, fibrous connective tissue decreased but collagen fibers became thick, with a few scattered inflammatory cells. A small amount of new fibrous bone tissue was found and osteoblasts began to appear and neatly arrange around fibrous bone-like structure. In the control group, inflammatory cells were widely distributed in fibrous tissue with some osteoclasts ( <ref type="figure" target="#fig_3">Figure 5</ref>). TW, TA, OBN, and OCN are shown in <ref type="table" target="#tab_5">Table  1</ref>; there was no statistical difference between A and B group at all 4 time points among these 4 indicators.</p><p>Brown granules appeared in cells after intracellular staining and brown flakes in intercellular substance during extracellular staining were both regarded as positive staining.  Immunohistochemical staining results of BMP-2 and TGF-b1 were almost the same and are displayed in <ref type="figure" target="#fig_4">Figure 6</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Previous research showed that an experimental bone defect should be larger than the area an animal can self-heal <ref type="bibr" target="#b10">[11]</ref>. This can realistically and effectively reflect the repair situation by materials or growth factor, and reduce the influence of factors such as species, age, and site <ref type="bibr" target="#b11">[12]</ref>. Critical-sized defect (CSD) was first proposed by Schmitz et al., who defined it as the minimal defect that cannot be repaired and healed in a lifetime by itself in a specific bone <ref type="bibr" target="#b12">[13]</ref>. CSD models of rats, dogs, and rabbits have been widely used, and the rabbit critical-sized cranial defect model is 15 mm in diameter and is a round bone defect <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b13">14]</ref>. In our study, the rabbit cranial defect was 15×15 mm and cannot self-repair, which has been confirmed in preliminary experiments and can realistically reflect the repairing situation using icariin and ACGF.</p><p>Epimedium is a genus of flowering plants in the family Berberidaceae and is a typical representative of Chinese herbal medicines (Yang) used to repair strengthen bone. Icariin, as the active component of Epimedium, was reported to have many physiological activities, which not only stimulate new bone formation and increase bone mass, but also promotes bone marrow stromal stem cell differentiation to osteoblasts and inhibits osteoclast differentiation <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>. In addition, except for promoting the expression of TGF-b in rat osteoblasts, icariin also can inhibit the expression of IL-6 and TNF-a, which can inhibit bone resorption and promote bone formation <ref type="bibr" target="#b17">[18]</ref>. Thus, icariin has been widely used and is a highly developed method to repair bone defects.  At present, there are 2 kinds of plasma extract in the field of oral and maxillofacial surgery: platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>. ACGF is isolated from venous blood, just like PRF. However, ACGF is completely without additives such as calcium chloride and bovine thrombin, and is safer than PRF in the control of infection. Studies had confirmed that ACGF can speed the reconstruction of new bone and does not cause viral infections <ref type="bibr" target="#b6">[7]</ref>. Due to its fibrous framework composed of various high-concentration growth factors and fibrous protein, ACGF is successfully used as a healing biological material. TGF-b can promote mitotic division of osteogenic precursor cells and fibroblast cells <ref type="bibr" target="#b20">[21]</ref>. PDGF can increase OBN, stimulate mitotic division of bone marrow stromal stem cells, and promote capillary regeneration <ref type="bibr" target="#b21">[22]</ref>. IGF is involved in the development and differentiation of bone, skin, and nerves, and also has the function of promoting mitosis <ref type="bibr" target="#b22">[23]</ref>. VEGF can promote differentiation of osteoblasts, fracture healing, formation of new blood vessels, and enhances permeability <ref type="bibr" target="#b23">[24]</ref>. In addition, the polymerization of fibrinogen molecules can capture fiber protein blocks to form a 3-dimensional polymer grid structure, which is thin, soft, osmotic, and rich in elastin. In bone repair and regeneration, fibrin coagulation plays an important role in mechanical support.</p><p>Osteoblasts determine the formation, development, reconstruction, and repair of bone <ref type="bibr" target="#b24">[25]</ref>. The change in OBN is an important factor that affects the balance of bone metabolism. TGF-b is a secreted protein that controls proliferation, cellular differentiation, and other functions in most cells and is widespread in animal bone tissue and platelets <ref type="bibr">[26]</ref>. Because of its extensive biological activity and variety of regulatory function, TGF-b can promote osteoblast proliferation and differentiation, inhibit the activity of osteoclasts, and promote fiber cells to secrete fiber mucin and collagen, which has an important regulatory role in bone cell growth, immunity, and differentiation. TGF-b is an important biological transmitter in injury. TGF-b1 is an important subtype of TGF-b, which can induce the differentiation of primary mesenchymal stem cells into cartilage tissue, and promote the proliferation and maturation of cartilage cells during the process of embryonic cartilage formation <ref type="bibr" target="#b26">[27]</ref>. BMP is a multifunctional growth factor in the TGF-b family; it is a highly conserved and functional protein with structure similar to that of other members of the family <ref type="bibr" target="#b27">[28]</ref>. Because it can induce bone and cartilage formation in vivo, BMP is called "osteogenin" or "bone morphogenetic protein". BMP-2 is the most widely studied BMP and is the most active in inducing osteogenesis. BMP-2 was widely found to be highly expressed in cartilage cells, osteoblasts, and their precursor cells <ref type="bibr" target="#b27">[28]</ref>.</p><p>In the present study, we compared the 2 methods of repairing rabbit cranial defect by icariin and ACGF pellicle. The results showed that, from the 4 th week, osteoblasts began to gather around the cranial edge with a cubic shape, a large and obvious nucleus, abundant cytoplasm, and regular arrangement. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Rabbit skull full-thickness defect with the integrity of the dura mater.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc>General observation of skull at 4 time points. First column is group A; second column is group B; third column is group C.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 .</head><label>4</label><figDesc>X-ray result of skull at 4 time points. First column is A group; second column is group B; third column is group C.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 5 .</head><label>5</label><figDesc>HE staining results of skull at 4 time points (HE ×400</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 6 .</head><label>6</label><figDesc>Immunohistochemical staining results of BMP-2 and TGF-b1 at 4 time points (Polymer ×400). First column is group A; second column is group B; third column is group C. Left 3 pictures are BMP-2, and right pictures are TGF-b1. BMP-2 and TGF-b1 were positive in intercellular substances among the 3 groups at the 2 nd week, which was the same at the 4 th week. BMP-2 and TGF-b1 were positive in intercellular substance and bone matrix at the 8 th week, and osteoblasts also showed positive at the 12 th week.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc>Samples were stained again with hematoxylin and then washed with water. After being packaged with neutral gum, samples were observed under a light microscope. In addition, PBS instead of antibody I was used as a negative control.</figDesc><table><row><cell>37°C with sheep</cell></row><row><cell>serum for 30 min to reduce nonspecific adsorption and then</cell></row><row><cell>washed with PBS 3 times. With monoclonal antibody BMP-2</cell></row><row><cell>(diluted concentration 1: 50) and TGFb1 (diluted concentra-</cell></row><row><cell>tion 1: 50Statistical</cell></row></table><note>2374 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System] [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica] [Chemical Abstracts/CAS] [Index Copernicus] Indicators At 2, 4, 8, and 12 weeks after surgery, all rabbits in the 3 groups were killed. Under sterile conditions, the skull was taken out and an X-ray was taken to observe bone defect healing. The new bone tissue was intercepted by 5 mm along the edge of the defect region and fixed for 48 h in 4% polyformaldehyde. A 4-μm decalcified bone tissue section was made for HE (he- matoxylin and eosin) staining. HE-stained tissue section was photographed under a light microscope to compare trabecu- lae width (TW), trabecular area (TA), osteoblast number (OBN), and osteoclast number (OCN). Expression of BMP-2 and TGF-1 protein detected by streptavidin-peroxidase (SP) immunohistochemistry Paraffin sections was made, routinely dewaxed in water, and soaked in 3% H 2 O 2 for 10 min and washed with PBS 3 times Figure 2. Repairing situation of bone defect at 4 time points. First column is A group; second column is group B; third column is group C.2375 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System] [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica] [Chemical Abstracts/CAS] [Index Copernicus] for 5 min each time. Samples were blocked at) (ZSGB-BIO, Beijing, China), immunohistochemical staining was done with biotin-labeled goat anti-mouse IgG (ZSGB-BIO, Beijing, China) and horseradish peroxidase-labeled streptavidin (ZSGB-BIO, Beijing, China) for 30 min and 20 min, respectively. 3,3'-diaminobenzidine (ZSGB-BIO, Beijing, China) was used to display color.analysis SPSS 19.0 software was used to analyze data. All data are ex- pressed as mean ±SD. Variance analysis was used to compare</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc>At 12 weeks, bone defects were covered with newly formed bone tissue with red color, hard surface, and no obvious boundary between the edges, forming normal physiological curvature of skull tissue. X-rays showed homogeneous low-density images with sharp edges of the bone defect at the 2 nd week in all 3 groups, and in groups A and B this changed to cloud-like low-density shadow at the 4 th</figDesc><table /><note>Figures 2 and 3. There were no differ- ences among the 3 groups at the 2 nd week, with central local depression and blurred boundary. A small amount of soft, thin, translucent new bone tissue appeared in groups A and B from the 4 th week. Bone fusion with normal bone tissue was obvi- ous (smooth surface, uniform thickness, slightly red color) at the 8 th week in groups A and B, but not group C.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc>). New bone was not observed at the 2 nd week. A few osteoblasts gathered around trabecular bone in groups A and B at the 4 th week. A large number of osteoblasts gathered around trabecular bone in groups A and B after 8 weeks. A few osteoblasts gathered around trabecular bone in group C. Mass of new bone was observed in groups A and B at 12 weeks, while masses of fibrous tissue gathered around trabecular bone in group C. First column is group A, second column is group B, third column is group C.</figDesc><table /><note>2378 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System] [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica] [Chemical Abstracts/CAS] [Index Copernicus]</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 1 .</head><label>1</label><figDesc>Comparisons of bone histomorphometric indicators among three groups (Mean ±SD, n=3).A group means icariine group; B group means ACGF group; C group means the control group. TA -means trabercular area; TW -means traberculae width; OBN -means osteoblast number; OCN -means osteoclast number. * When this group compared with the control group, P&lt;0.05.</figDesc><table><row><cell>Indicator</cell><cell>C group</cell><cell>A group</cell><cell>B group</cell></row><row><cell>2 th week</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TA (%)</cell><cell>9.12±3.02</cell><cell>17.67±3.55*</cell><cell>17.33±3.95*</cell></row><row><cell>TW (µm)</cell><cell>186.11±24.53</cell><cell>290.32±24.89*</cell><cell>291.45±24.52*</cell></row><row><cell>OBN</cell><cell>10.31±5.14</cell><cell>31.11±5.67*</cell><cell>31.24±5.22*</cell></row><row><cell>OCN</cell><cell>5.19±0.55</cell><cell>4.03±0.50*</cell><cell>4.02±0.53*</cell></row><row><cell>4 th week</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TA (%)</cell><cell>19.04±3.94</cell><cell>37.88±4.10*</cell><cell>37.81±3.91*</cell></row><row><cell>TW (µm)</cell><cell>225.17±28.53</cell><cell>312.13±27.69*</cell><cell>311.02±27.72*</cell></row><row><cell>OBN</cell><cell>20.11±4.45</cell><cell>49.74±4.67*</cell><cell>47.55±4.53*</cell></row><row><cell>OCN</cell><cell>4.88±0.78</cell><cell>3.19±0.80*</cell><cell>3.17±0.78*</cell></row><row><cell>8 th week</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TA (%)</cell><cell>28.12±3.56</cell><cell>45.55±3.66*</cell><cell>46.01±3.58*</cell></row><row><cell>TW (µm)</cell><cell>299.36±13.58</cell><cell>419.10±37.10*</cell><cell>417.90±38.15*</cell></row><row><cell>OBN</cell><cell>29.64±8.41</cell><cell>60.12±7.36*</cell><cell>58.17±8.38*</cell></row><row><cell>OCN</cell><cell>4.53±0.66</cell><cell>1.75±0.47*</cell><cell>1.77±0.55*</cell></row><row><cell>12 th week</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TA (%)</cell><cell>43.16±5.45</cell><cell>67.00±5.60*</cell><cell>66.97±5.58*</cell></row><row><cell>TW (µm)</cell><cell>377.97±29.17</cell><cell>579.88±30.23*</cell><cell>580.03±29.91*</cell></row><row><cell>OBN</cell><cell>20.35±4.91</cell><cell>35.71±4.87*</cell><cell>36.03±4.77*</cell></row><row><cell>OCN</cell><cell>1.99±0.74</cell><cell>1.94±0.88</cell><cell>1.95±0.79</cell></row></table><note>2379 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System] [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica] [Chemical Abstracts/CAS] [Index Copernicus]</note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>We acknowledge the assistance of investigators and all subjects in this study.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This illustrates that the osteoblasts were significantly more active than in the control group. Osteoblast activity reached a peak at the 8 th week, with a single, large, and clear nucleus, 1-nucleolus, and a fence-like arrangement around bone and trabecular bone. At the 12 th week, trabecular bone thickened and OBN stabilized, which was significantly higher than in the control group. There was no significant difference in new bone formation or new bone density in the icariin and ACGF groups, but they were both higher than in the control group, indicating that icariin and ACGF both can accelerate the quality and speed of bone healing and achieve almost the same effect. X-ray, HE staining, histological observation, and immunohistochemistry almost showed the same results. Positive expression of BMP-2 and TGF-b1 gradually increased after cranial defects were repaired by icariin and ACGF pellicle for 2, 4, 8, and 12 weeks, suggesting that icariin and ACGF pellicle can quickly and effectively initiate formation of various cytokines related to osteogenesis, promote the formation of cartilage matrix and the proliferation and differentiation of osteoblasts, inhibit the formation of osteoclasts, and accelerate the repair and healing of bone defects.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>ACGF and icariin both can increase new bone quantity and improve the quality of healing. They also can promote the quality and rate of healing. The effect of ACGF and icariin on healing of bone defects was nearly identical (P&gt;0.05).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p>The author(s) declare that they have no competing interests. In addition, this research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Tissue engineering for bone defect healing: An update on a multi-component approach</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Inga</forename><surname>Drosse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elias</forename><surname>Volkmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rodolfo</forename><surname>Capanna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pietro</forename><forename type="middle">De</forename><surname>Biase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wolf</forename><surname>Mutschler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><surname>Schieker</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0020-1383(08)70011-1</idno>
		<idno type="PMID">18804579</idno>
	</analytic>
	<monogr>
		<title level="j">Injury</title>
		<title level="j" type="abbrev">Injury</title>
		<idno type="ISSN">0020-1383</idno>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="S9" to="S20" />
			<date type="published" when="2008-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>Suppl. 2</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Growth and remodeling in a thick-walled artery model: effects of spatial variations in wall constituents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">W</forename><surname>Alford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jay</forename><forename type="middle">D</forename><surname>Humphrey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Larry</forename><forename type="middle">A</forename><surname>Taber</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10237-007-0101-2</idno>
		<idno type="PMID">17786493</idno>
		<idno type="PMCID">PMC2594015</idno>
		<idno type="ark">ark:/67375/VQC-S1Z13ZFG-C</idno>
		<idno type="istexId">100C7B7ADAB73F98D5CD1FC1C0B21914D5824F82</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2594015?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biomechanics and Modeling in Mechanobiology</title>
		<title level="j" type="abbrev">Biomech Model Mechanobiol</title>
		<idno type="ISSN">1617-7959</idno>
		<idno type="ISSNe">1617-7940</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="245" to="262" />
			<date type="published" when="2007-09-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hui-Ping</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lei-Guo</forename><surname>Ming</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bao-Feng</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuan-Kun</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cory</forename><forename type="middle">J</forename><surname>Xian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ke-Ming</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcb.23007</idno>
		<idno type="PMID">21328465</idno>
		<idno type="ark">ark:/67375/WNG-PLPFDTWS-W</idno>
		<idno type="istexId">8A62A75260FA58F36B5216755474636BE9E1971C</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Cellular Biochemistry</title>
		<title level="j" type="abbrev">J. Cell. Biochem.</title>
		<idno type="ISSN">0730-2312</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="916" to="923" />
			<date type="published" when="2011-02-16" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Songgang</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ping</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jianwei</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jie</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiangsong</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wenguang</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaozhou</forename><surname>Fei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhiping</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhiwei</forename><surname>Quan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yingbin</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2010.07.009</idno>
		<idno type="PMID">20674153</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Letters</title>
		<title level="j" type="abbrev">Cancer Letters</title>
		<idno type="ISSN">0304-3835</idno>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="222" to="230" />
			<date type="published" when="2010-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Byung-Hee</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jong-Dai</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chun-Ki</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung</forename><forename type="middle">Huan</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Moo-Ho</forename><surname>Won</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Han-Soo</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mi-Sook</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kwon-Soo</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Geun</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Myeong</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2008.09.001</idno>
		<idno type="PMID">18789310</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<title level="j" type="abbrev">Biochemical and Biophysical Research Communications</title>
		<idno type="ISSN">0006-291X</idno>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="404" to="408" />
			<date type="published" when="2008-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Progressive studies on effects of traditional Chinese medicines on differentiation of human bone mesenchymal stem cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Zhongguo Zhong Yao Za Zhi</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1892" to="95" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note>in Chinese</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">International academy of implant prosthesis and osteoconnection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lecture</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">4</biblScope>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luigi</forename><forename type="middle">Fabrizio</forename><surname>Rodella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gaia</forename><surname>Favero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ramon</forename><surname>Boninsegna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><surname>Buffoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauro</forename><surname>Labanca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giorgio</forename><surname>Scarì</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luigi</forename><surname>Sacco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tiziano</forename><surname>Batani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rita</forename><surname>Rezzani</surname></persName>
		</author>
		<idno type="DOI">10.1002/jemt.20968</idno>
		<idno type="PMID">21780251</idno>
		<idno type="ark">ark:/67375/WNG-WSSR6ZDQ-H</idno>
		<idno type="istexId">79E2D60144FE46EBEE7F1CFAA6DE4C20FB2EF388</idno>
	</analytic>
	<monogr>
		<title level="j">Microscopy Research and Technique</title>
		<title level="j" type="abbrev">Microsc. Res. Tech.</title>
		<idno type="ISSN">1059-910X</idno>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="772" to="777" />
			<date type="published" when="2011-07-21" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Anitua</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Oral Maxillofac Implants</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="529" to="564" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Mandibular reconstruction: A clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P M</forename><surname>Fennis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J W</forename><surname>Stoelinga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Jansen</surname></persName>
		</author>
		<idno type="DOI">10.1054/ijom.2002.0151</idno>
		<idno type="PMID">12190135</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Oral and Maxillofacial Surgery</title>
		<title level="j" type="abbrev">International Journal of Oral and Maxillofacial Surgery</title>
		<idno type="ISSN">0901-5027</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="281" to="286" />
			<date type="published" when="2002-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Clinically Applied Models of Bone Regeneration in Tissue Engineering Research</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">A</forename><surname>Einhorn</surname></persName>
		</author>
		<idno type="DOI">10.1097/00003086-199910001-00007</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Orthopaedics and Related Research</title>
		<title level="j" type="abbrev">Clinical Orthopaedics and Related Research</title>
		<idno type="ISSN">0009-921X</idno>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="issue">367</biblScope>
			<biblScope unit="page" from="S59" to="S67" />
			<date type="published" when="1999-10" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The monocortical critical size bone defect as an alternative experimental model in testing bone substitute materials</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karl</forename><forename type="middle">Andreas</forename><surname>Schlegel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Friedemann</forename><forename type="middle">Johannes</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karl</forename><surname>Donath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jochen</forename><forename type="middle">Theodor</forename><surname>Kulow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jörg</forename><surname>Wiltfang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tripleo.2005.09.011</idno>
		<idno type="PMID">16831666</idno>
	</analytic>
	<monogr>
		<title level="j">Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology</title>
		<title level="j" type="abbrev">Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology</title>
		<idno type="ISSN">1079-2104</idno>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="7" to="13" />
			<date type="published" when="2006-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The Critical Size Defect as an Experimental Model for Craniomandibulofacial Nonunions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">P</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">O</forename><surname>Hollinger</surname></persName>
		</author>
		<idno type="DOI">10.1097/00003086-198604000-00036</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Orthopaedics and Related Research</title>
		<title level="j" type="abbrev">Clinical Orthopaedics and Related Research</title>
		<idno type="ISSN">0009-921X</idno>
		<imprint>
			<biblScope unit="volume">&amp;NA;</biblScope>
			<biblScope unit="issue">205</biblScope>
			<biblScope unit="page">299???308</biblScope>
			<date type="published" when="1986-04" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Importance of the Critical-Size Bone Defect in Testing Bone-Regenerating Materials</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carles</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Birte</forename><surname>Melsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karin</forename><surname>Vargervik</surname></persName>
		</author>
		<idno type="DOI">10.1097/00001665-199807000-00004</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Craniofacial Surgery</title>
		<title level="j" type="abbrev">Journal of Craniofacial Surgery</title>
		<idno type="ISSN">1049-2275</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="310" to="316" />
			<date type="published" when="1998-07" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lan</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xi</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tian-Lan</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kui</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lfs.2007.07.015</idno>
		<idno type="PMID">17764702</idno>
	</analytic>
	<monogr>
		<title level="j">Life Sciences</title>
		<title level="j" type="abbrev">Life Sciences</title>
		<idno type="ISSN">0024-3205</idno>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="832" to="840" />
			<date type="published" when="2007-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaowei</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fuxing</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haoyang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhen</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhouyuan</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pengde</forename><surname>Kang</surname></persName>
		</author>
		<idno type="DOI">10.1177/0885328215581551</idno>
		<idno type="PMID">25876888</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Biomaterials Applications</title>
		<title level="j" type="abbrev">J Biomater Appl</title>
		<idno type="ISSN">0885-3282</idno>
		<idno type="ISSNe">1530-8022</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="290" to="299" />
			<date type="published" when="2015-04-14" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuqiong</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lunguo</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuning</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuanjin</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xinquan</forename><surname>Jiang</surname></persName>
		</author>
		<idno type="DOI">10.1111/cpr.12185</idno>
		<idno type="PMID">25867119</idno>
		<idno type="ark">ark:/67375/WNG-94FHGSQ9-D</idno>
		<idno type="istexId">A1C91215E62B334F4F581FBA76C55334D43DBD21</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Proliferation</title>
		<title level="j" type="abbrev">Cell Prolif.</title>
		<idno type="ISSN">0960-7722</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="375" to="384" />
			<date type="published" when="2015-04-13" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Bone Morphogenic Protein-4 Induces Hypertension in Mice: Role of Noggin, Vascular NADPH Oxidases, and Impaired Vasorelaxation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Miriyala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">M</forename><surname>Gongora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Mingone</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.106.611822</idno>
		<idno type="PMID">16769910</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.106.611822" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="2818" to="2825" />
			<date type="published" when="2006-06-20" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">M</forename><surname>Dohan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><surname>Choukroun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antoine</forename><surname>Diss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steve</forename><forename type="middle">L</forename><surname>Dohan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><forename type="middle">J J</forename><surname>Dohan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaafar</forename><surname>Mouhyi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruno</forename><surname>Gogly</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tripleo.2005.07.008</idno>
		<idno type="PMID">16504849</idno>
	</analytic>
	<monogr>
		<title level="j">Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology</title>
		<title level="j" type="abbrev">Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology</title>
		<idno type="ISSN">1079-2104</idno>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="e37" to="e44" />
			<date type="published" when="2006-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte-and plateletrich fibrin (L-PRF)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">D</forename><surname>Dohan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Rasmusson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Albrektsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Biotechnol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="158" to="67" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Angiogenesis and bone repair</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A D</forename><surname>Carano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ellen</forename><forename type="middle">H</forename><surname>Filvaroff</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1359-6446(03)02866-6</idno>
		<idno type="PMID">14643161</idno>
	</analytic>
	<monogr>
		<title level="j">Drug Discovery Today</title>
		<title level="j" type="abbrev">Drug Discovery Today</title>
		<idno type="ISSN">1359-6446</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="980" to="989" />
			<date type="published" when="2003-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Activation of platelet-rich plasma using thrombin receptor agonist peptide</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Regina</forename><surname>Landesberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Pinsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Vo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sidney</forename><forename type="middle">B</forename><surname>Eisig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><forename type="middle">H</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.joms.2004.12.007</idno>
		<idno type="PMID">15789326</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Oral and Maxillofacial Surgery</title>
		<title level="j" type="abbrev">Journal of Oral and Maxillofacial Surgery</title>
		<idno type="ISSN">0278-2391</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="529" to="535" />
			<date type="published" when="2005-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Rotwein</surname></persName>
		</author>
		<idno type="DOI">10.1152/physrev.1996.76.4.1005</idno>
		<idno type="PMID">8874492</idno>
	</analytic>
	<monogr>
		<title level="j">Physiological Reviews</title>
		<title level="j" type="abbrev">Physiological Reviews</title>
		<idno type="ISSN">0031-9333</idno>
		<idno type="ISSNe">1522-1210</idno>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1005" to="1026" />
			<date type="published" when="1996-10" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Molecular and biological properties of vascular endothelial growth factor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Napoleone</forename><surname>Ferrara</surname></persName>
		</author>
		<idno type="DOI">10.1007/s001099900019</idno>
		<idno type="PMID">10494799</idno>
		<idno type="ark">ark:/67375/VQC-BGRM0X3W-N</idno>
		<idno type="istexId">159D29768BCDC8FDABEBED37AB69975408A8B45A</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Medicine</title>
		<title level="j" type="abbrev">J Mol Med</title>
		<idno type="ISSN">0946-2716</idno>
		<idno type="ISSNe">1432-1440</idno>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="527" to="543" />
			<date type="published" when="1999-07" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Alternative causes of hypopituitarism: Traumatic brain injury, cranial irradiation, and infections</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Pekic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Popovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Handb Clin Neurol</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="271" to="90" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Growth Factors and Cartilage Repair</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wim</forename><forename type="middle">B</forename><surname>Van Den Berg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">M</forename><surname>Van Der Kraan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alwin</forename><surname>Scharstuhl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henk</forename><forename type="middle">M</forename><surname>Van Beuningen</surname></persName>
		</author>
		<idno type="DOI">10.1097/00003086-200110001-00023</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Orthopaedics and Related Research</title>
		<title level="j" type="abbrev">Clinical Orthopaedics and Related Research</title>
		<idno type="ISSN">0009-921X</idno>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="S244" to="S250" />
			<date type="published" when="2001-10" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Effect of transforming growth factor β1 on chondrogenic differentiation of cultured equine mesenchymal stem cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allison</forename><forename type="middle">A</forename><surname>Worster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">J</forename><surname>Nixon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brent</forename><forename type="middle">D</forename><surname>Brower-Toland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janice</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.2460/ajvr.2000.61.1003</idno>
		<idno type="PMID">10976727</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Veterinary Research</title>
		<title level="j" type="abbrev">American Journal of Veterinary Research</title>
		<idno type="ISSN">0002-9645</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1003" to="1010" />
			<date type="published" when="2000-09" />
			<publisher>American Veterinary Medical Association (AVMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Signal transduction of bone morphogenetic proteins in osteoblast differentiation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Ten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Schaap</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Roelen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Joint Surg Am</title>
		<imprint>
			<biblScope unit="page" from="34" to="38" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
	<note>Suppl. 3</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m">Current Contents/Clinical Medicine</title>
		<imprint/>
	</monogr>
	<note>SCI Expanded. ISI Alerting System. ISI Journals Master List. Index Medicus/MEDLINE. Chemical Abstracts/CAS. Index Copernicus</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
